There could be new hope on for kidney cancer patients. Researchers announced early results of an anti-tumor vaccine for ...
This article was originally published by The 19th.
Dana-Farber Cancer Institute researchers report that all nine patients in a clinical trial being treated for stage III or IV ...
In a small clinical trial of nine patients with stage III and IV kidney cancer, a personalized anti-tumor vaccine generated ...
A personalized neoantigen cancer vaccine generated strong immune responses in renal cell carcinoma patients, leading to ...
All nine patients treated at Dana-Farber Cancer Institute ... generated a successful anti-cancer immune response after initiation of a personalized cancer vaccine. The vaccines were administered ...
All patients involved in the phase 1 trial of a personalized cancer vaccine for high-risk stage III/IV kidney cancer showed a ...
Robert F. Kennedy Jr, a vaccine critic and the newly-appointed US health secretary, thanked "MAHA moms" before senators voted ...
“We found neoantigen-targeting vaccines in [kidney cancer] are highly immunogenic, capable of targeting key driver mutations (such as VHL) in kidney cancer and induce anti-tumor immunity ...